Alyeska Investment Group’s Guardant Health GH Stock Holding History

Alyeska Investment Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.2M	Sell	647,818 -841,748	-57%	-$91.5M	0.25%	104
2026 Q1	$138M	Buy	1,489,566 +145,912	+11%	+$14.6M	0.39%	59
2025 Q4	$137M	Sell	1,343,654 -487,664	-27%	-$43.6M	0.39%	59
2025 Q3	$114M	Buy	+1,831,318	New	+$99.6M	0.35%	74
2022 Q2	–	Sell	-709,779	Closed	-$47M	–	604
2022 Q1	$47M	Buy	709,779 +463,212	+188%	+$31.7M	0.52%	58
2021 Q4	$24.7M	Buy	+246,567	New	+$25.5M	0.28%	117
2019 Q3	–	Sell	-27,399	Closed	-$2.37M	–	442
2019 Q2	$2.37M	Sell	27,399 -25,111	-48%	-$1.92M	0.03%	301
2019 Q1	$4.03M	Buy	+52,510	New	+$2.91M	0.05%	240

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Alyeska Investment Group's GH Position: Q2 2026 in Review

Alyeska Investment Group reduced its Guardant Health (GH) stake by 57% in Q2 2026, selling an estimated $91.5M and leaving 647,818 shares worth $97.2M. The position accounts for 0.25% of the portfolio, ranked #104.

Alyeska Investment Group first reported a position in GH in Q1 2019 and has held it in 8 quarters since. The position peaked at $138M in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Alyeska Investment Group held 647,818 shares of Guardant Health worth $97.2M as of Q2 2026.
Alyeska Investment Group sold 841,748 Guardant Health shares in Q2 2026, an estimated $91.5M.
Guardant Health made up 0.25% of Alyeska Investment Group's portfolio in Q2 2026, its #104 holding.
Alyeska Investment Group first reported a position in Guardant Health in Q1 2019 and has held it in 8 quarters since.
Alyeska Investment Group's Guardant Health position peaked at $138M in Q1 2026.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.